NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

They [NWBO management] continue to avoid questions on marketing application timelines, commercial manufacturing ability timelines, etc. They and their pals then get angry anyone should dare raise questions about their plans. They provide topline but after years of saying it would be imminently backed up with a journal, get mad at investors for wondering when the journal is coming out. It just seems like anger at investors is their posture. They didn’t change clinicaltrials.gov endpoints until after topline, even though Dr. Ashkan seems to confirm it was approved by all four regulators beforehand. Les’s old saw about catching shorts off guard has proven quite the opposite. They did not surprise anyone with their NYAS or ASCO delivery, and left out timelines to boot. Again helping bears. The science appears good, and partial results appear good, but they leave a gap on follow up journal timing that might otherwise confirm matters.

No one could have stated this better.

The argument that they had vague purposes which we are not given to know just does not stand up by comparison.

The ASM would be the best time (besides yesterday, so to speak) for NWBO to address these issues but of course, they won't and it seems they are delaying even the need to duck and dodge at the ASM for as long as possible.